Actionable news
0
All posts from Actionable news
Actionable news in JNJ: JOHNSON & JOHNSON,

J&J psoriasis drug Stelara tames Crohn's disease in second trial

Johnson & Johnson's Stelara psoriasis drug has shown effectiveness against Crohn's disease in a second late-stage trial, the company said on Friday, bolstering prospects of its approval for the additional use.

The study showed Stelara induced remissions in moderate to severe Crohn's disease patients who had previously failed to benefit from TNF inhibitors, a leading class of medicines for the inflammatory bowel disease. Those treatments...


More